Classics in Cardiovascular Endocrinology: Aldosterone Action Beyond Electrolytes.
作者信息
Auchus Richard J
机构信息
Division of Metabolism, Diabetes, and Endocrinology, Department of Internal Medicine, Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor, Michigan 48019.
出版信息
Endocrinology. 2016 Feb;157(2):429-31. doi: 10.1210/en.2015-2061. Epub 2015 Dec 23.
Abstract
摘要
相似文献
1
Classics in Cardiovascular Endocrinology: Aldosterone Action Beyond Electrolytes.心血管内分泌学经典著作：醛固酮在电解质之外的作用
Endocrinology. 2016 Feb;157(2):429-31. doi: 10.1210/en.2015-2061. Epub 2015 Dec 23.
2
The ups and downs of the renin-angiotensin-aldosterone system since Tigerstedt's first discovery of renin.自蒂格斯特德首次发现肾素以来肾素-血管紧张素-醛固酮系统的兴衰历程
Endocr Res. 1998 Aug-Nov;24(3-4):781-8. doi: 10.3109/07435809809032688.
3
[Water and electrolyte imbalance and the renin-angiotensin-aldosterone system].[水与电解质失衡及肾素-血管紧张素-醛固酮系统]
Nihon Jinzo Gakkai Shi. 1973 Jul;15(7):629-34.
4
5
50th anniversary of aldosterone.醛固酮发现50周年。
J Clin Endocrinol Metab. 2003 Jun;88(6):2364-72. doi: 10.1210/jc.2003-030490.
6
[Renin-angiotensin-aldosterone system in water-electrolyte homeostasis].[肾素-血管紧张素-醛固酮系统与水电解质平衡]
Med Interna (Bucur). 1972 May;24(5):521-8.
7
[The role of the renin-aldosterone system in osmoregulatory reactions of healthy subjects in response to desmopressin].[肾素-醛固酮系统在健康受试者对去氨加压素的渗透调节反应中的作用]
Fiziol Cheloveka. 2005 Sep-Oct;31(5):110-6.
8
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).肾素-血管紧张素-醛固酮系统对血压和电解质平衡的作用及其在高血压、充血性心力衰竭以及相关心血管损伤（心肌梗死和中风）中的作用。
J Hum Hypertens. 1995 Jun;9(6):385-90.
9
[Hormonal regulation of water-electrolyte metabolism (a lecture)].[水-电解质代谢的激素调节（讲座）]
Ter Arkh. 1989;61(10):83-7.
10
Aldosterone--a hormone of cardiovascular adaptation and maladaptation.醛固酮——一种与心血管适应及适应不良相关的激素。
J Clin Hypertens (Greenwich). 2006 Feb;8(2):133-9. doi: 10.1111/j.1524-6175.2006.05110.x.
引用本文的文献
1
Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases.心血管内分泌学：相关疾病的概念演变与最新流行病学
Front Endocrinol (Lausanne). 2021 Oct 5;12:772876. doi: 10.3389/fendo.2021.772876. eCollection 2021.
2
Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System.使用原发性醛固酮增多症手术结果（PASO）分类系统完善原发性醛固酮增多症生化治愈和临床治愈的定义
World J Surg. 2018 Feb;42(2):453-463. doi: 10.1007/s00268-017-4311-1.
3
Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.终末期肾病的盐皮质激素受体阻断。
Curr Hypertens Rep. 2017 May;19(5):40. doi: 10.1007/s11906-017-0737-y.
4
Signaling Interactions in the Adrenal Cortex.肾上腺皮质中的信号相互作用
Front Endocrinol (Lausanne). 2016 Feb 29;7:17. doi: 10.3389/fendo.2016.00017. eCollection 2016.
本文引用的文献
1
Long-Term Effects of Low-Dose Spironolactone on Chronic Dialysis Patients: A Randomized Placebo-Controlled Study.小剂量螺内酯对慢性透析患者的长期影响：一项随机安慰剂对照研究。
J Clin Hypertens (Greenwich). 2016 Feb;18(2):121-8. doi: 10.1111/jch.12628. Epub 2015 Jul 30.
2
Effects of spironolactone on dialysis patients with refractory hypertension: a randomized controlled study.螺内酯对难治性高血压透析患者的影响：一项随机对照研究。
J Clin Hypertens (Greenwich). 2014 Sep;16(9):658-63. doi: 10.1111/jch.12374. Epub 2014 Jul 22.
3
The general adaptation syndrome and the diseases of adaptation.一般适应综合征与适应性疾病
J Clin Endocrinol Metab. 1946 Feb;6:117-230. doi: 10.1210/jcem-6-2-117.
4
Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism.原发性醛固酮增多症的高血压患者中可逆性交感神经活性亢进。
J Clin Endocrinol Metab. 2010 Oct;95(10):4756-61. doi: 10.1210/jc.2010-0823. Epub 2010 Jul 21.
5
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.低钾血症型和正常血钾型原发性醛固酮增多症的心血管和脑血管合并症：德国Conn登记研究结果
J Clin Endocrinol Metab. 2009 Apr;94(4):1125-30. doi: 10.1210/jc.2008-2116. Epub 2009 Feb 3.
6
Cardiovascular outcomes in patients with primary aldosteronism after treatment.原发性醛固酮增多症患者治疗后的心血管结局
Arch Intern Med. 2008 Jan 14;168(1):80-5. doi: 10.1001/archinternmed.2007.33.
7
Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.肾上腺切除术或盐皮质激素拮抗剂对原发性醛固酮增多症患者的长期心脏影响。
Hypertension. 2007 Nov;50(5):911-8. doi: 10.1161/HYPERTENSIONAHA.107.095448. Epub 2007 Sep 24.
8
Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?给予盐皮质激素/盐后，糖皮质激素受体阻断会加重组织损伤吗？
Endocrinology. 2007 Oct;148(10):4829-35. doi: 10.1210/en.2007-0209. Epub 2007 Jul 19.
9
Renal damage in primary aldosteronism: results of the PAPY Study.原发性醛固酮增多症中的肾损害：PAPY研究结果
Hypertension. 2006 Aug;48(2):232-8. doi: 10.1161/01.HYP.0000230444.01215.6a. Epub 2006 Jun 26.
10
Long-term renal outcomes in patients with primary aldosteronism.原发性醛固酮增多症患者的长期肾脏结局
JAMA. 2006 Jun 14;295(22):2638-45. doi: 10.1001/jama.295.22.2638.
Zotero 插件